The Role of Therapeutic Inertia and the Use of Fixed‐Dose Combination Therapy in the Management of Hypertension

Abstract

On April 9, 2007, a panel discussion was held to discuss the role of therapeutic inertia and the value of using fixed‐dose combination therapy in the management of hypertension. The panel was moderated by Jan Basile, MD, Professor of Medicine, Ralph H. Johnson VA Medical Center, Charleston, SC. Discussants included Henry R. Black, MD, Clinical Professor Internal Medicine, New York University School of Medicine, New York, NY, John A. Flack, MD, MPH, Professor and Interim Chair and Chief, Division of Translational Research and Epidemiology, Department of Medicine, Wayne State University, Detroit, MI, and Joseph L. Izzo, Professor and Vice Chair, State University of New York at Buffalo, Buffalo, NY. This expert panel discussion was supported by Novartis and each author received an honorarium from Novartis for time and effort spent participating in the discussion and reviewing the transcript for important intellectual content prior to publication. The authors maintained full control of the discussion and the resulting content of this article.